Professor Sandra Lindstedt is a senior consultant in cardiothoracic surgery specializing in heart and lung transplantation, with a long-standing interest in lung transplantation-related research, post-transplant complications and lung regeneration. Professor Lindstedt did her post-doc in the early 2000s and was part of the team who did the first clinical trial in the world using ex vivo lung perfusion on marginal donor lungs in 2005 at Lund University Hospital, Sweden.
Professor Lindstedt is the principal investigator for a translational research group. The Lindstedt group has created ex vivo human models and in vivo and ex vivo porcine models of lung injuries and a pig lung transplantation survival model. The Lindstedt group are currently working to develop therapies within these models and aim to bring this research towards clinical applications. The eventual aim is to treat damaged donor lungs, increase the number of lungs suitable for transplantation, and reduce complications after lung transplantation such as primary graft dysfunction.